Jonathan Dowell Selected Research

Carcinoma (Carcinomatosis)

1/2020	Osimertinib in Pulmonary Manifestations: Two Case Reports and Review of the Literature.
3/2003	Amifostine and curative intent chemoradiation for compromised cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan Dowell Research Topics

Disease

5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 01/2005
4	Neoplasms (Cancer) 10/2021 - 03/2003
2	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2015
2	Carcinoma (Carcinomatosis) 01/2020 - 03/2003
1	Mesothelioma 01/2024
1	Lymphadenopathy 10/2021
1	Weight Loss (Weight Reduction) 10/2021
1	Stroke (Strokes) 08/2021
1	Adenocarcinoma of Lung 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Inflammation (Inflammations) 01/2019
1	Dyspnea (Shortness of Breath) 09/2015
1	Esophagitis 09/2015
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2015
1	Disease Progression 12/2014
1	Papillary Thyroid Cancer 12/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2012
1	Keratoacanthoma 12/2012
1	Melanoma (Melanoma, Malignant) 12/2012
1	Embolic Stroke 05/2012
1	Patent Foramen Ovale 05/2012
1	Philadelphia Chromosome 03/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2012
1	Acute Promyelocytic Leukemia 03/2012
1	Constipation 09/2006
1	Anemia 09/2006
1	Nausea 09/2006
1	Diarrhea 09/2006
1	Vomiting 09/2006
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2003

Drug/Important Bio-Agent (IBA)

2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2005
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2014 - 01/2005
1	TAS-114IBA 10/2020
1	DeoxyuridineIBA 10/2020
1	GlucocorticoidsIBA 01/2020
1	osimertinibIBA 01/2020
1	Hormones (Hormone)IBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 07/2015
1	veliparibIBA 07/2015
1	Etoposide (VP 16)FDA LinkGeneric 07/2015
1	IpilimumabIBA 12/2012
1	cobimetinibIBA 12/2012
1	VemurafenibIBA 12/2012
1	Immunomodulating AgentsIBA 12/2012
1	Dacarbazine (DIC)FDA LinkGeneric 12/2012
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2012
1	Imatinib Mesylate (Gleevec)FDA Link 03/2012
1	Amifostine (Ethyol)FDA LinkGeneric 03/2003

Therapy/Procedure

5	Therapeutics 01/2024 - 12/2012
4	Drug Therapy (Chemotherapy) 01/2020 - 03/2003
3	Radiotherapy 10/2021 - 12/2014
1	Immunotherapy 01/2022
1	Chemoradiotherapy 10/2021
1	Length of Stay 08/2021
1	Indwelling Catheters (Indwelling Catheter) 05/2012
1	Pain Management 09/2006
1	Combined Modality Therapy 03/2003